ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

BTAI BioXcel Therapeutics Inc

2.12
0.00 (0.00%)
Pre Market
Last Updated: 04:55:14
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 000137k238k206k457k341k
Operating Income -26.13M-31.48M-36.29M-38.98M-52.89M-51.2M-52.41M-48.3M
Pre Tax Income -26.13M-31.47M-37.67M-41.81M-54.81M-52.8M-53.52M-50.49M
Net Income -26.13M-31.47M-37.67M-41.81M-54.81M-52.8M-53.52M-50.49M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -26.13M-31.48M-36.29M-38.93M-53.32M-51.44M-52.12M-48.3M
EBITDA -26.06M-31.4M-36.2M-38.9M-52.81M-51.12M-52.33M-48.22M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 000000375k1.38M
Operating Income -2.12M-4.54M-19.96M-33.6M-82.3M-106.94M-159.65M-171.78M
Pre Tax Income -2.12M-4.54M-19.27M-32.97M-82.17M-106.93M-165.76M-179.05M
Net Income -2.12M-4.54M-19.27M-32.97M-82.17M-106.93M-165.76M-179.05M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0-0.458-1.23-1.823-3.365-3.822-5.889-6.117
EBIT -2.12M-4.54M-19.96M-33.6M-82.3M-106.94M-160.07M-171.39M
EBITDA -2.12M-4.54M-19.95M-33.45M-82.11M-106.64M-159.32M-171.46M

Your Recent History

Delayed Upgrade Clock